
Laurus Labs Limited has informed the Exchange regarding a press release dated November 19, 2021, titled "Laurus Labs acquires substantial minority stake in a CAR-Tcell therapy company - ImmunoACT.".
Filed with NSE ·

Laurus Labs Limited has informed the Exchange regarding a press release dated November 19, 2021, titled "Laurus Labs acquires substantial minority stake in a CAR-Tcell therapy company - ImmunoACT.".
6ix hasn’t read this filing yet.
Follow Laurus Labs into a list and get an email when it puts out news.
Follow Laurus Labs